{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/44567-705#drug","name":"Imipenem and Cilastatin","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"44567-705"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA207594"},{"@type":"PropertyValue","propertyID":"UNII","value":"5428WXZ74M|Q20IM7HE75"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"46f54df9-5afe-430c-aa19-0d84c2044b0b"}],"activeIngredient":"CILASTATIN SODIUM, IMIPENEM ANHYDROUS","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, POWDER, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"WG Critical Care, LLC"},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA207594","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=46f54df9-5afe-430c-aa19-0d84c2044b0b","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=44567-705"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-10-30T11:33:05.790Z"}}